Skip to content
Search

Latest Stories

Suppressing pharmacy funding crisis analysis would be ‘outrageous’, warns NPA

NPA urges immediate release of pharmacy funding crises review
Underfunding has forced record numbers of pharmacy closures (gettyimages)

The NPA fears the report won’t be published until pharmacy funding consultations conclude, while CPE states there is no set timeline for finalising negotiations.

The National Pharmacy Association (NPA) has called on the NHS and the Department of Health to immediately publish the government-commissioned analysis of pharmacy underfunding and reveal the true scale of the crisis.

Commissioned by NHS England, the long-awaited independent review is expected to “lay bare the perilous financial state” of community pharmacies, which is a vital part of the nation’s health infrastructure.


However, the NPA is concerned that the government may delay its release until after current funding consultations are concluded.

The NPA argued that the public needs to understand the fragile nature of the pharmacy network before any new deal can be agreed.

It has also warned health officials not to hide “the true scale of funding needed to reverse a decade of swingeing cuts”, which has forced record numbers of pharmacy closures.

NPA chair Nick Kaye said: “It would be a scandal to keep that evidence buried secret and leave MPs, pharmacies and the public in the dark.”

He acknowledged that the new government has inherited a crisis in pharmacy funding and emphasised that it will need to take “strong action” to maintain access to medicines.

Highlighting that pharmacies are closing at an alarming rate and those that remain are being forced to cut opening hours to stay open, he called for “full and immediate transparency about the funding required to protect the pharmacy network upon which millions rely.”

The association has demanded an urgent resolution to budget discussions to ensure that much-needed funds reach hard pressed pharmacies.

“Pharmacies need an urgent conclusion to consultations on pharmacy funding that protects the network that is so vital to millions of people. They cannot wait,” Kaye said.

Work to influence government spending ongoing, says CPE

Meanwhile, Community Pharmacy England (CPE) has confirmed to Pharmacy Business that negotiations on the 2024/25 and 2025/26 funding framework are ongoing, with no definitive timeline set for their conclusion.

“This item in the 2025/26 workplan (which commences in April 2025) relates to work which goes into negotiations, analysis, and any necessary implementation work. Implementation work can go on for many months, depending on what is agreed, and work to influence Government spending is ongoing,” CPE stated.

When launching the funding consultation in January, pharmacy minister Stephen Kinnock reaffirmed his commitment to working closely with CPE to agree “a package of funding that is reflective of the important support that they provide to patients up and down the country.”

CPE chief executive Janet Morrison had said the committee would very carefully consider whether “the proposals that the government is putting on the table address the severity of the funding crisis in community pharmacy.”

She noted that while community pharmacy sector can play a vital role in delivering government’s long term health plans, this will only be possible if “the sector is put on a sustainable financial footing.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less